Equities
Health CareHealth Care Equipment & Services
  • Price (USD)326.19
  • Today's Change2.06 / 0.64%
  • Shares traded1.17m
  • 1 Year change+58.96%
  • Beta0.6999
Data delayed at least 15 minutes, as of Sep 23 2021 19:18 BST.
More ▼
Take Survey
Help shape our future virtual events & community services
Take part in our survey for a chance to win a free 3-month standard gift subscription.

Profile data is unavailable for this security.

About the company

Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through three segments: Life Sciences, which offers a range of instruments and consumables that are used by customers to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies, and test and manufacture new drugs and vaccines; Diagnostics, which offers analytical instruments, reagents, consumables, software and services, and Environmental & Applied Solutions, which offers products and services that help protect important resources and keep global food and water supplies safe. Its business research and development, manufacturing, sales, distribution, service and administrative facilities are located in over 60 countries.

  • Revenue in USD (TTM)26.72bn
  • Net income in USD5.36bn
  • Incorporated1986
  • Employees67.00k
  • Location
    Danaher Corp2200 Pennsylvania Ave NW Ste 800wWASHINGTON 20037-1731United StatesUSA
  • Phone+1 (202) 828-0850
  • Fax+1 (202) 828-0860
  • Websitehttps://www.danaher.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
DHR:NYQ since
announced
Transaction
value
Aldevron LLCDeal completed17 Jun 202117 Jun 2021Deal completed33.28%9.60bn
Data delayed at least 15 minutes, as of Sep 23 2021 19:18 BST.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
SMC Corp5.53bn1.32bn47.16bn20.62k35.273.6031.608.532,179.172,179.179,144.3321,336.870.40471.293.5729,434,020.009.659.2410.5010.2648.3950.1323.8422.456.44--0.007521.814.983.0310.225.744.0720.11
Roper Technologies Inc5.99bn1.07bn48.60bn18.40k45.904.3828.928.1210.0410.0456.45105.190.27879.865.86325,413.004.966.405.617.2164.6463.0917.8020.680.63286.370.439717.172.999.06-46.286.416.1615.44
Agilent Technologies Inc6.14bn990.00m52.20bn16.70k53.7210.5640.068.503.213.2119.9116.320.61313.645.99374,512.209.888.8911.6510.5553.6553.6816.1215.791.6317.600.366224.683.415.74-32.8710.423.9610.26
Sartorius AG3.40bn391.87m53.67bn11.98k132.7936.5068.1815.794.904.9042.5217.830.64172.318.65273,390.7010.248.3314.7111.6652.5950.8615.9612.350.744919.700.565424.2927.8415.9444.4121.5016.6113.30
Emerson Electric Co.17.85bn2.36bn57.09bn83.50k24.406.1417.163.203.913.9129.6515.540.77244.935.78213,736.5010.319.2114.2413.3141.7442.3613.3511.710.997320.540.439264.23-8.640.6512-14.79-4.83-1.761.25
HOYA CORPORATION5.43bn1.28bn61.52bn37.25k48.339.5437.7211.32378.03378.031,600.831,914.520.7211.155.5616,018,100.0017.0315.0919.3017.9984.6384.3323.6220.273.92--0.029829.20-4.961.629.726.1511.433.71
Illumina, Inc.3.97bn768.00m63.75bn7.80k83.5012.2566.2716.085.205.2026.8935.480.49823.058.58508,461.509.6512.5511.0215.3368.6368.6619.3624.215.64--0.24480.00-8.587.85-34.537.285.74--
Danaher Corporation26.72bn5.36bn231.40bn67.00k43.905.8631.328.667.387.5036.6059.900.35794.246.97398,798.507.404.858.075.4359.2455.6620.6814.281.88127.450.323217.6624.429.0748.4814.989.057.05
Data as of Sep 23 2021. Currency figures normalised to Danaher Corp's reporting currency: US Dollar USD

Institutional shareholders

30.83%Per cent of shares held by top holders
HolderShares% Held
The Vanguard Group, Inc.as of 30 Jun 202146.75m6.55%
T. Rowe Price Associates, Inc. (Investment Management)as of 30 Jun 202131.98m4.48%
BlackRock Fund Advisorsas of 30 Jun 202130.17m4.23%
Fidelity Management & Research Co. LLCas of 30 Jun 202126.24m3.68%
SSgA Funds Management, Inc.as of 30 Jun 202125.21m3.53%
Wellington Management Co. LLPas of 30 Jun 202119.24m2.70%
Massachusetts Financial Services Co.as of 30 Jun 202114.08m1.97%
Geode Capital Management LLCas of 30 Jun 202110.02m1.40%
Edgewood Management LLCas of 30 Jun 20218.23m1.15%
Northern Trust Investments, Inc.(Investment Management)as of 30 Jun 20218.19m1.15%
More ▼
Data from 30 Jun 2021 - 30 Jun 2021Source: FactSet Research Systems Inc.
Refinitiv, an LSEG business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
image